Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00379041

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Not specified

View Trial Details

Active, not recruiting

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

NCT00002462

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Algemeen Ziekenhuis Middelheim Antwerp, Belgium

A.Z. St. Jan Bruges, Belgium

Hopital Universitaire Erasme Brussels, Belgium

C.H.U. Saint-Pierre Brussels (Bruxelles), Belgium

View all 56 locations

View Trial Details

Active, not recruiting

A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma

NCT05860036

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Active, not recruiting

Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.

NCT07101913

Conditions: Acute Kidney Injury, Acute Kidney Injury (AKI), B Cell Lymphoma, +18 more
Locations: Nephrology department, Centre hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Active, not recruiting

Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma

NCT07094477

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Active, not recruiting

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

NCT06944119

Conditions: Bone Marrow Diseases, CLL, Hematologic Diseases, +13 more
Locations: Tel Aviv Sourasky Medical Center Tel Aviv, Israel

View Trial Details

Active, not recruiting

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

NCT02911142

Conditions: B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients

NCT07088783

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Dokuz Izmir, Turkey (Türkiye)

View Trial Details

Active, not recruiting

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385

Conditions: ALL, Recurrent, Adult, Disease Attributes, Hematologic Diseases, +15 more
Locations: Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany

Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany

University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany

Universitätsklinikum Dresden Dresden, Saxony, Germany

View all 17 locations

View Trial Details

Active, not recruiting

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

NCT04052880

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions